,Pearls,Clothing, Shoes Jewelry , Women , Jewelry,/kersey570877.html,Necklace,$30,Of,Dogeared,Success,16",Pearls,Clothing, Shoes Jewelry , Women , Jewelry,/kersey570877.html,Necklace,$30,Of,Dogeared,Success,16" famous Dogeared Pearls Of 16" Success Necklace famous Dogeared Pearls Of 16" Success Necklace $30 Dogeared Pearls Of Success Necklace 16" Clothing, Shoes Jewelry Women Jewelry $30 Dogeared Pearls Of Success Necklace 16" Clothing, Shoes Jewelry Women Jewelry

famous Dogeared Pearls Of Soldering 16

Dogeared Pearls Of Success Necklace 16"


Dogeared Pearls Of Success Necklace 16"


Product description

  • Thanks to their dedication to sustainability, Dogeared® is proud to call themselves a Certified B Corporation brand.
  • Pearls are truly a hallmark of success. The Dogeared® Pearls of Success Necklace 16" will remind you that you are confident and capable of accomplishing anything in life.
  • With time, patience, and a little help from Mother Nature, a pearl grows into an object of beauty and simplicity. Pearls represent the best in us...something beautiful that comes from within. Wear your necklace as a reminder that you are beautiful, inside and out.
  • Sterling silver or gold-dipped sterling silver with 4mm freshwater button pearl.
  • Spring ring clasp.
  • Handcrafted in California.
  • Each Dogeared Jewels necklace and bracelet is packaged in a sweet and sturdy gift box.
  • Measurements:
    • Chain Circumference: 16 in
    • Pendant Height: 1⁄4 in
    • Pendant Width: 1⁄4 in
    • Weight: 0.04 oz

Dogeared Pearls Of Success Necklace 16"

September, 2021

No. 106 (9)

2020 Impact Factor: 9.941 Submission > Acceptance: 52 days

Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma

This open-label, single-arm study investigated the long-term efficacy of tafasitamab plus lenalidomide in 81 patients with relapsed/refractory diffuse large B-cell lymphoma. The response rate was 57.5%, including complete responses in 40.0% of patients, and the median duration of response was 43.9 months. This treatment is a valuable option for patients not eligible for autologous stem-cell transplantation.

Johannes Duell et al.

Case Report

Clinical genomic profiling of novel grey zone lymphoma paired lesions with sequential central nervous system involvement in two adolescent patients

Grey zone lymphoma is a B-cell lymphoma, unclassifiable, with features intermediate between those of large B-cell lymphoma and classic Hodgkin lymphoma. The in-depth study of the two adolescent patients described in this case report expands the clinicopathological and genomic spectrum of this rare pediatric disease. Moreover, it provides information on their response to treatment.

Cagla Y. Benkli et al.


CAMT-MPL: congenital amegakaryocytic thrombocytopenia caused by MPL mutations - heterogeneity of a monogenic disorder - a comprehensive analysis of 56 patients

The clinical picture of 56 patients with congenital amegakaryocytic thrombocytopenia due to MPL mutations was much more varied than previously thought. Twenty-five per cent of them had no signs of thrombocytopenia at birth, and 50% had non-hematologic defects. Pancytopenia developed in (nearly) all patients and hematopoietic stem-cell transplantation was effective in 87% of cases.

Manuela Germeshausen et al.


Oxidative stress activates red cell adhesion to laminin in sickle cell disease

Sickle red blood cells exhibit abnormal adhesion to laminin mediated by Lu/BCAM protein at their surface. This study provides evidence of the involvement of oxidative stress in post-translational modifications of Lu/BCAM which impact the protein’s distribution and cis-interaction with glycophorin C at the cell surface activating its adhesive function in dense sickle red cells. The authors speculate that antioxidant drugs might attenuate this phenomenon.

Maria Alejandra Lizarralde-Iragorri et al.